GlassScriptPhysician profile
Matthew Michael Levitsky
NPI 1083145924
$4,508.48
in general payments reported to CMS, 2019-2025
12 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $104 · 2021: $273 · 2022: $313 · 2023: $2,754 · 2024: $239 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,884 · Food and Beverage: $1,278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,883.93 |
| Food and Beverage | $1,277.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $2,287.72 | 2022-2023 | Amistem, Gmk Sphere, M-Vizion |
| Stryker Corporation | $809.24 | 2019-2023 | Mako |
| Depuy Synthes Sales INC. | $674.19 | 2019-2024 | Actis, Na, Fibergraft Bg Morsels |
| Arthrex, INC. | $268.65 | 2023-2025 | Distal Extremities Implants Trauma, Distal Extremities Implants Trauma Ankle Fracture |
| Zimmer Biomet Holdings, INC. | $185.30 | 2019-2021 | |
| Smith+Nephew, INC. | $77.31 | 2023 | Real Intelligence, Journey II, Redapt |
| Solventum Corporation | $68.59 | 2024-2025 | Prevena |
| Evolution Surgical, INC | $48.38 | 2025 | |
| Kerecis Limited | $30.56 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Pacira Pharmaceuticals Incorporated | $29.34 | 2023 | Iovera, Zilretta, Exparel |
| Bioventus LLC | $15.60 | 2025 | Durolane |
| Fidia Pharma USA INC. | $13.60 | 2024 | Hyalgan, Triluron, Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Levitsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.